Home » Public Policy

State & Local Issues

Bright Spot for Biotech: Golden State Leads in Jobs
Taking the Pulse of Bioscience Education in America
Guide to Biotechnology 2008

We have used the biological processes of microorganisms for 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.

2007-2008 BIO Milestones

Today, the biotechnology industry is enjoying more success and influence than ever before. Our industry’s innovations continue to improve the lives of people worldwide, and the advancement of these innovations is supported by the work of BIO.

Growing The Nation's Biotech Sector

States and regions throughout the United States are investing to create a business climate that supports the specific needs of the biosciences sector.

Growing The Nation's Biotech Sector

Letters, Testimony & Comments

BIO's letter to FL Governor Scott Regarding Substitution of Biosimilar Medicines
May 8 2013
BIO  urges Florida Governor Scott to sign House Bill 365 – a bill related to the substitution of biologic and biosimilar medicines – which recently passed out of the Legislature.
Letter Supporting Florida House Bill 365; Pertaining to requirements for pharmacist to dispense substitute biological product
February 1 2013
BIO supports passage of Florida House Bill 365, which provides requirements for pharmacist to dispense substitute biological products that are determined to be interchangeable for prescribed biological product.
BIO Principles on Patient Safety in the Substitution of Biologic Products
January 24 2013
To ensure transparency and communication between patients and their treatment teams, BIO believes that certain safeguards should guide substitution policies for interchangeable biologics under state law as well.
Statement in Support Of North Dakota S.B. 2190
January 24 2013
The policies outlined in Senate Bill 2190 align with all five of BIO’s Principles on Biologic Product Substitution and we therefore support its passage.
Statement in Opposition to North Dakota S. 2066
January 24 2013
BIO opposes the proposal to subject certain cancer therapies to prior authorization measures under Senate Bill 2066.
More Letters, Testimony & Comments →

Press Releases

Governor Kitzhaber Signs Legislation to Create Pathway for Substitution of Biologic Drugs
June 7 2013
Oregon Governor John Kitzhaber signed legislation on Thursday, June 6 designed to address the regulatory issues related to the interchangeability of biological medicines.
New Florida Law Takes a Major Step in Promoting Access to Biologic Medicines
June 5 2013
House Bill 365, signed by Governor Rick Scott, contains four of BIO’s five principles on biologic product substitution
Repeal of Florida’s Renewable Fuel Standard Will Stifle Innovation, Investment and Jobs, BIO Says
June 3 2013
Florida's repeal of the state Renewable Fuel Standard could chill investment, innovation and job creation within the state's biotechnology industry.
BIO Releases Bioscience Economic Development Report and Guide
April 23 2013
The Biotechnology Industry Organization (BIO) released its “Bioscience Economic Development: Legislative Priorities, Best Practices, and Return On Investment” report today at the 2013 BIO International Convention.  
Administration’s Budget Proposal Undercuts Development of Cures and Breakthroughs, and Hurts Job Growth
April 11 2013
“BIO stands ready to work with the Administration to develop policies that help spur innovation, foster economic opportunity, discover new cures and create jobs,” BIO President and CEO Jim Greenwood said.
More Press Releases →